Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial.
Journal: Dermatology and therapy
Published: October 04, 2021
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 24, 2021
The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.
Journal: The British journal of dermatology
Published: April 06, 2021
The Effect of Tildrakizumab on Cardiometabolic Risk Factors in Psoriasis by Metabolic Syndrome Status: Post Hoc Analysis of Two Phase 3 Trials (ReSURFACE 1 and ReSURFACE 2).
Journal: Journal of drugs in dermatology : JDD
Published: August 27, 2020
Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 01, 2020
Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2).
Journal: Journal of the American Academy of Dermatology
Published: February 10, 2020
How can we manage the safety concerns associated with the increase in biologics for psoriasis?
Journal: Expert opinion on drug safety
Published: January 18, 2020
Erythema Ab Igne and Malignant Transformation to Squamous Cell Carcinoma.
Journal: Cutis
Published: January 01, 2020
IL-17 inhibitors for psoriasis.
Journal: Seminars in cutaneous medicine and surgery
Published: September 15, 2018
Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas.
Journal: Expert opinion on pharmacotherapy
Published: March 23, 2018
Practical Strategies for Optimizing Management of Psoriasis.
Journal: Seminars in cutaneous medicine and surgery
Published: February 01, 2018
The Evolving Landscape of Psoriasis Treatment.
Journal: Seminars in cutaneous medicine and surgery
Published: February 01, 2018
Last Updated: 09/26/2026